Calcipotriol-plus–5-FU therapy activates immune pathways, offering long-lasting protection against squamous cell carcinoma by ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for Marginal Zone B-cell Lymphoma.

Calquence is under clinical development by AstraZeneca and currently in Phase II for Graft Versus Host Disease (GVHD).

Since Tregs, particularly those committed in the thymus (tTregs), play a non-redundant role in the ... CVID patients are characterized by decreased class-switched memory B cells (4) but autoimmune ...

B-cell lymphoma is a type of blood cancer that affects the B lymphocytes of the immune system. They usually arise in the lymph nodes or in other lymphoid tissue, such as the spleen, bone marrow ...

Sham thymectomy involved a complete surgical procedure without thymic lobe removal. Thymectomized mice were allowed a six-week recovery period. For single-cell suspension preparation, tumors were ...

The 3-month-old girl who lives in a bubble can’t get hugs from her grandparents. Cuddling, holding and just being in the same room are off-limits too for everyone except her mother and 6-year ...

in a Lymph Node of F.M. after Antigenic Stimulation (X90), Contrasted with the"Thymus-Dependent" Zone (B) of the Lymph-Node Subcortex of C.P. (X180) — Reticular Cells Are Prominent, and ...

Your immune cells are what they eat Scientists establish novel link between cell nutrition and identity, say targeting nutrient-dependent activity could improve immunotherapies Date: December 12 ...

While B-cell lymphoma always originates in white blood cells called B cells, different B-cell lymphomas vary in aggressiveness, prognosis, and response to treatment. Some B-cell lymphomas can be cured ...